Samuel O'Brient

Samuel O'Brient

Expertise: Global Financial Markets, Macroeconomics and Geopolitics

Education: BA, Economics & Political Science, Sarah Lawrence College; MSc, International Politics, Trinity College Dublin

Awards & Accomplishments: Published in Curlew Quarterly. Quoted in Forbes. Interviewed by Foreign Policy.

About Samuel
Samuel O’Brient is a Reporter for InvestorPlace, where his work focuses primarily on financial markets, global economic trends, and public policy. O’Brient writes a weekly column on recent political news that investors should be following.

From his early days at InvestorPlace, O’Brient found himself drawn to the booming world of electric vehicles and green energy. His coverage of mining and other battery components has made him an expert source for industry publications. During his early years as an Economic Policy Analyst at U.S. Resist News, he gained expertise in international trade as the U.S.-China trade war dominated headlines. This in-depth research and analysis experience helped strengthen his prowess in all things political economy. O’Brient brings this expertise to work with him every day, thoughtfully analyzing how the daily happenings on the Capitol trickle down to Wall Street… and how retail investors can take action to profit.

An experienced journalist, editor, and economic policy analyst, O’Brient has spent his career guided by a deep passion for economic theory and policy. As a financial blogger on TipRanks, he has received 4.6 stars and is ranked in the top 10% of stock pickers.

O’Brient’s work on economic and tech policy has been curated by popular outlets Marker, OneZero and Gen.

He can be reached on LinkedIn and Muck Rack.

Recent Articles

Apple Rumors: AAPL Stock Ticks Higher on New iPhone SE Release Date

Apple is gearing up to release the iPhone SE as shoppers gear up for a complicated holiday season. AAPL stock is enjoying the ride so far.

Amazon’s Alabama Workers Get Second Shot at a Union. What Does That Mean for AMZN Stock?

Amazon has been called on its union vote interference. Here's what this news may mean for AMZN stock as the next union vote nears.

VIR Stock Pops Amid Renewed Omicron Variant Concerns. Here’s Why.

Vir Biotechnology has a Covid-19 treatment that its CEO says will do well against new variants. Amid uncertainty, VIR stock is climbing.

IBIO Stock Surges as the Biotech Company Looks to Leverage Omicron Fears

IBIO stock may have missed out on the success of larger vaccine makers, but it's hoping the omicron variant will change that.

MTTR Stock Alert: Why One Analyst Thinks Matterport Is a Top Omicron-Beating Pick

One analyst thinks Matterport will prove a breakout company as the omicron variant rises. Here's what to consider when evaluating MTTR stock.